Home/article/PharmEasy plans Rs. 2400 crores rights issue at 90% discount.

PharmEasy plans Rs. 2400 crores rights issue at 90% discount.

Written by: Diksha Kalra

Published: Sep 16, 2026

Updated: Sep 16, 2026

1 min read

To pay back its debt from Goldman Sachs, PharmEasy plans to raise around Rs 2,400 crore through a rights issue at a 90% discount to its highest stock price. Existing shareholders, TPG and Temasek, are leading the rights issue. Ranjan Pai, chairman of the Manipal group, is likely to invest Rs 1,000 crore in the rights issue. Pai is expected to join the company’s board.

PharmEasy will issue new stock at Rs 5 per share. The rights issue will likely take place at a valuation of around $500 Mn-$600 Mn, a sharp drop from its valuation of $5.6 Bn in 2021.

Stay Connected, Stay Informed –

Join Our

Channel!

Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.